Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus Recommendations
- 1 August 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 49 (8), 1331-1336
- https://doi.org/10.1373/49.8.1331
Abstract
Background: The European Society of Cardiology/American College of Cardiology (ESC/ACC) consensus document for definition of myocardial infarction (MI) is predicated on increased cardiac troponin or creatine kinase (CK) MB mass above the 99th percentile reference limit. The purpose of this study was to determine the plasma (heparin) 99th percentile reference limits for the leading in vitro diagnostic cardiac troponin and CKMB mass assays. Methods: Blood (heparin plasma) was obtained from healthy adults (n = 696; age range, 18–84 years) stratified by gender and ethnicity. Cardiac troponin I (cTnI) and T (cTnT) and CKMB mass concentrations were measured by eight assays. Reference limits were determined by nonparametric statistical analysis. Results: Two cTnI assays demonstrated at least a 1.2- to 2.5-fold higher 99th percentile for males vs females, with the mean concentrations significantly higher for males (P <0.05). Two cTnI assays also demonstrated a 1.1- to 2.8-fold higher 99th percentile for blacks vs Caucasians, with the mean concentrations significantly higher for blacks (P = 0.05). There was a 13-fold variance between the lowest measured 99th percentile (0.06 μg/L) and the highest (0.8 μg/L). All CKMB assays demonstrated a 1.2- to 2.6-fold higher 99th percentile for males vs females, with mean concentrations significantly higher for males (P <0.0001). Four CKMB assays also showed significantly higher (1.2- to 2.7-fold) mean concentrations for blacks (P <0.02) vs Caucasians. Conclusions: The heparin-plasma 99th percentile reference limits for cardiac troponin and CKMB mass provide an evidence base in support of the ESC, ACC, and American Heart Association guidelines for detection of myocardial injury. Selective gender and ethnic differences were demonstrated. These data allow clinicians, trialists, and epidemiologists a common point for operational use.Keywords
This publication has 24 references indexed in Scilit:
- Operationalizing cardiac troponin I testing along ESC/ACC consensus guidelines for defining myocardial infarction: increasing rate of detectionClinica Chimica Acta; International Journal of Clinical Chemistry, 2003
- European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trialsAmerican Heart Journal, 2002
- The New Definition of Myocardial InfarctionArchives of Internal Medicine, 2002
- Multicenter Evaluation of an Automated Assay for Troponin IClinical Chemistry, 2002
- Measurement of Cardiac TroponinsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2001
- Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromesAmerican Heart Journal, 2000
- It’s Time for a Change to a Troponin StandardCirculation, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarctionJournal of the American College of Cardiology, 2000
- Biochemical Factors Influencing Measurement of Cardiac Troponin I in Serumcclm, 1999